Replies to post #353 on Atossa Therapeutics Inc (ATOS)

[~S.B.A.~]

huge potential detecting hyperplasia of the breast at age 18 and a done deal w/ McKesson. No brainer here

[~S.B.A.~]

late Dec then 90 days out or with-in next catalyst, which the stock could see $5-$6 range if 510k gets accepted. I'm betting w/ the institutions who just gave them millions and Mckesson who still is on board. Closely watching here